These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25924725)

  • 1. Multivariate meta-analysis of prognostic factor studies with multiple cut-points and/or methods of measurement.
    Riley RD; Elia EG; Malin G; Hemming K; Price MP
    Stat Med; 2015 Jul; 34(17):2481-96. PubMed ID: 25924725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients.
    Petrelli F; Viale G; Cabiddu M; Barni S
    Breast Cancer Res Treat; 2015 Oct; 153(3):477-91. PubMed ID: 26341751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study.
    Healey MA; Hirko KA; Beck AH; Collins LC; Schnitt SJ; Eliassen AH; Holmes MD; Tamimi RM; Hazra A
    Breast Cancer Res Treat; 2017 Nov; 166(2):613-622. PubMed ID: 28791482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
    Kurozumi S; Matsumoto H; Hayashi Y; Tozuka K; Inoue K; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
    BMC Cancer; 2017 May; 17(1):354. PubMed ID: 28532429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariate meta-analysis using individual participant data.
    Riley RD; Price MJ; Jackson D; Wardle M; Gueyffier F; Wang J; Staessen JA; White IR
    Res Synth Methods; 2015 Jun; 6(2):157-74. PubMed ID: 26099484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvessel density as a prognostic factor in non-small-cell lung carcinoma: a meta-analysis of individual patient data.
    Trivella M; Pezzella F; Pastorino U; Harris AL; Altman DG;
    Lancet Oncol; 2007 Jun; 8(6):488-99. PubMed ID: 17513172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years.
    Mirza AN; Mirza NQ; Vlastos G; Singletary SE
    Ann Surg; 2002 Jan; 235(1):10-26. PubMed ID: 11753038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.
    Zenzola V; Cabezas-Quintario MA; Arguelles M; Pérez-Fernández E; Izarzugaza Y; Correa A; García-Foncillas J
    Clin Transl Oncol; 2018 Nov; 20(11):1448-1454. PubMed ID: 29671222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of effect sizes reported at multiple time points: a multivariate approach.
    Trikalinos TA; Olkin I
    Clin Trials; 2012 Oct; 9(5):610-20. PubMed ID: 22872546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy.
    Ács B; Zámbó V; Vízkeleti L; Szász AM; Madaras L; Szentmártoni G; Tőkés T; Molnár BÁ; Molnár IA; Vári-Kakas S; Kulka J; Tőkés AM
    Diagn Pathol; 2017 Feb; 12(1):20. PubMed ID: 28222768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up.
    Bustreo S; Osella-Abate S; Cassoni P; Donadio M; Airoldi M; Pedani F; Papotti M; Sapino A; Castellano I
    Breast Cancer Res Treat; 2016 Jun; 157(2):363-371. PubMed ID: 27155668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.
    Denkert C; Loibl S; Müller BM; Eidtmann H; Schmitt WD; Eiermann W; Gerber B; Tesch H; Hilfrich J; Huober J; Fehm T; Barinoff J; Jackisch C; Prinzler J; Rüdiger T; Erbstösser E; Blohmer JU; Budczies J; Mehta KM; von Minckwitz G
    Ann Oncol; 2013 Nov; 24(11):2786-93. PubMed ID: 23970015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate meta-analysis of individual participant data helped externally validate the performance and implementation of a prediction model.
    Snell KI; Hua H; Debray TP; Ensor J; Look MP; Moons KG; Riley RD
    J Clin Epidemiol; 2016 Jan; 69():40-50. PubMed ID: 26142114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis.
    Loehberg CR; Almstedt K; Jud SM; Haeberle L; Fasching PA; Hack CC; Lux MP; Thiel FC; Schrauder MG; Brunner M; Bayer CM; Hein A; Heusinger K; Heimrich J; Bani MR; Renner SP; Hartmann A; Beckmann MW; Wachter DL
    Breast Cancer Res Treat; 2013 Apr; 138(3):899-908. PubMed ID: 23479421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients.
    de Azambuja E; Cardoso F; de Castro G; Colozza M; Mano MS; Durbecq V; Sotiriou C; Larsimont D; Piccart-Gebhart MJ; Paesmans M
    Br J Cancer; 2007 May; 96(10):1504-13. PubMed ID: 17453008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature.
    Liu Y; Yin W; Yan T; Du Y; Shao Z; Lu J
    Curr Med Res Opin; 2013 Nov; 29(11):1453-61. PubMed ID: 23927551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic model based on combining estrogen receptor expression and Ki-67 value after neoadjuvant chemotherapy predicts clinical outcome in locally advanced breast cancer: extension and analysis of a previously reported cohort of patients.
    Miglietta L; Morabito F; Provinciali N; Canobbio L; Meszaros P; Naso C; Murialdo R; Boitano M; Salvi S; Ferrarini M
    Eur J Surg Oncol; 2013 Oct; 39(10):1046-52. PubMed ID: 23890870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.